Home/Publication/Cowin Doubles Down on Flu Antivirals Developer
Cowin Doubles Down on Flu Antivirals Developer 

27 Jun 2024

US$ 19.00

Cowin Capital has made a follow-on investment in the over Rmb200 million (US$27.5 million) series A funding round of ......

Price / article: US$19.00
OR existing subscriber
Related Publications

Asian Infrastructure Investment Bank (AIIB), a multilateral development bank focusing on sustainable economic ......

Boyu Capital (Boyu) is to take a 60% equity interest in a joint venture with Starbucks Corp (Starbucks) to manage ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.